Some of the world's largest pharma companies are using Aiforia's software for biomarker discovery, improving preclinical workflow efficiency, and seamlessly working remotely with multi-site teams thanks to the cloud-based platform.
Aiforia's cloud-based deep learning artificial intelligence (AI) solutions and services for image analysis and pathology applications cater to all therapy areas.
Over 400 AI models have been created with Aiforia's solutions so far for image analysis tasks in tox path studies for example to automate bone marrow screening, standardize the evaluation of DSS colitis models, and more.
Global pharmaceutical and biotechnology organizations can unbind their workflows, scientists, and pathologists from time-consuming tasks, subjective results, hardware-heavy technology, and inefficient processes with Aiforia.